This is the Scientific Surgery Archive, which contains all randomized clinical trials in surgery that have been identified by searching the top 50 English language medical journal issues since January 1998. Compiled by Jonothan J. Earnshaw, former Editor-in-Chief, BJS
Adjuvant Imatinib for high-risk GI stromal tumor: analysis of a randomized trial. J Clin Oncol 2016; 34: 244-250.
Published: 25th August 2016
Authors: Joensuu H, Eriksson M, Hall KS, Reichardt A, Hartmann JT, Pink D et al.
Conclusion
In a study that included 400 patients followed for a median of 19 months, three years of imatinib improved five year relapse- free survival (71 versus 52.3 per cent, P<0.001), and overall survival (91.9 versus 85.3 per cent, P=0.036).
Pubmed Link